Source comparison
CJC-1295 no DAC & Ipamorelin with Food Safety: Comparison
Subcutaneous (CJC-1295 no DAC & Ipamorelin) 90%+ None—bypasses GI tract entirely Bacterial contamination during reconstitution; improper injection site rotation 2–8°C refrigeration post-reconstitution; use within 28 days Yes—bacteriostatic water required Steri
This comparison does not assign a generated winner or score.
- Subcutaneous (CJC-1295 no DAC & Ipamorelin)
- 90%+
- None—bypasses GI tract entirely
- Bacterial contamination during reconstitution; improper injection site rotation
- 2–8°C refrigeration post-reconstitution; use within 28 days
- Yes—bacteriostatic water required
- Sterile technique and cold chain management matter infinitely more than meal timing. Food timing only affects research variable control (GH measurement), not safety.
- Oral Peptide (e.g., BPC-157 capsule)
- 5–15%
- Significant—stomach pH, digestive enzymes, food volume all affect absorption
- Gastric degradation; inconsistent bioavailability
- Room temperature stable in capsule form
- No—pre-formulated
- Take on empty stomach to maximize limited absorption—but food presence is a pharmacokinetic variable, not a contamination risk.
- Intravenous (research-grade peptides in clinical trials)
- 100%
- None—direct bloodstream entry
- Infection at catheter site; requires medical supervision
- Strict cold chain; single-use vials only
- Sterile saline or specified diluent per trial protocol
- Food irrelevant; contamination control is hospital-grade protocol with documented chain-of-custody for every vial.